Snapshot from Jul 07, 2026 at 07:00 UTC. For live data and tracking: View Live
Other

Biologics license application

Tracked across 1 events · 7 articles · First seen Mar 10, 2026 · Last active Mar 31, 2026

Sentiment
-70
Attention
6
Events
1
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
6 -70
Regulatory
Impact: The timing of UniQure's Biologics license application for AMT-130 became 'unclear' after the United States — Food and Drug Administration revealed its disagreement with the company's study data.
Mar 10, 2026 · 7 articles
ERGEN INTELLIGENCE
Track Biologics license application live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.